Background: Angiotensin-converting enzyme (ACE) inhibitors prevent the expansion and
rupture of aortic aneurysms in animals. We investigated the association between ACE …

Background Angiotensin-converting enzyme (ACE) inhibitors prevent the expansion and
rupture of aortic aneurysms in animals. We investigated the association between ACE …

OBJECTIVES: To evaluate whether either angiotensin converting enzyme (ACE) inhibitors
or other classes of antihypertensive drug attenuate or increase growth rates of small …

found that use of an angiotensin-converting-enzyme (ACE) inhibitor in the past year,
including the past 3 months, was negatively associated with admission for ruptured …

Frank Lederle and Brent Taylor focus on our sensitivity analysis, which showed an
increased risk of rupture in patients who discontinue angiotensin-converting-enzyme (ACE) …

Objective Whether angiotensin II blockade is an effective medical treatment for abdominal
aortic aneurysms (AAAs) has not been established. This systematic review and meta …

Objective—The renin–angiotensin system is thought to play a pivotal role in the
pathogenesis of abdominal aortic aneurysms (AAAs). However, effects of angiotensin …

Objectives Optimal blood pressure control following endovascular (EVAR) or open
abdominal aneurysm repair (OAR) is crucial in reducing post repair complications. In …

Abdominal aortic aneurysm is a potentially fatal disorder, defined as a focal dilatation
exceeding 150% of the normal arterial diameter, with the risk for rupture increasing as …

Introduction Literature regarding pharmacological manipulation of aneurysm development
and progression is abundant; however studies looking at preventing rupture are sparse …